Guardant Health (GH) News Today

$24.95
-0.41 (-1.62%)
(As of 10:39 AM ET)
Guardant Health, Inc. (NASDAQ:GH) Short Interest Update
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 10,160,000 shares, an increase of 6.3% from the April 15th total of 9,560,000 shares. Based on an average daily trading volume, of 1,920,000 shares, the days-to-cover ratio is presently 5.3 days.
Guardant Health (NASDAQ:GH) Trading 4.7% Higher
Guardant Health (NASDAQ:GH) Stock Price Up 4.7%
Guardant Health (NASDAQ:GH) Shares Gap Up to $19.44
Guardant Health Inc.
142,745 Shares in Guardant Health, Inc. (NASDAQ:GH) Bought by Beck Bode LLC
Beck Bode LLC bought a new position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 142,745 shares of the company's stock, valued at approximately $3,861,00
Canaccord Genuity Group Cuts Guardant Health (NASDAQ:GH) Price Target to $30.00
Canaccord Genuity Group dropped their price target on Guardant Health from $45.00 to $30.00 and set a "buy" rating for the company in a research note on Monday.
abrdn plc Acquires New Holdings in Guardant Health, Inc. (NASDAQ:GH)
abrdn plc acquired a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 346,084 shares of the company's stock, valued at approximately $9,362,000. abrdn plc owned 0.29% of Guardant Health as of its mos
Jennison Associates LLC Sells 1,411,038 Shares of Guardant Health, Inc. (NASDAQ:GH)
Jennison Associates LLC decreased its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 74.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 479,846 shares of the company's stock after selling 1
Guardant Health (NASDAQ:GH) Coverage Initiated by Analysts at Craig Hallum
Craig Hallum began coverage on shares of Guardant Health in a research note on Wednesday. They issued a "buy" rating and a $28.00 price objective on the stock.
Guardant Health, Inc. (NASDAQ:GH) Shares Purchased by Sumitomo Mitsui Trust Holdings Inc.
Sumitomo Mitsui Trust Holdings Inc. lifted its position in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 207.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 343,745 shares of the company's stock aft
Guardant Health (NASDAQ:GH) Shares Gap Up to $16.07
Guardant Health (NASDAQ:GH) Shares Gap Up to $16.07
Traders Purchase Large Volume of Guardant Health Call Options (NASDAQ:GH)
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) was the recipient of some unusual options trading on Monday. Stock investors purchased 5,660 call options on the company. This represents an increase of approximately 175% compared to the average daily volume of 2,057 call options.
Federated Hermes Inc. Sells 202,300 Shares of Guardant Health, Inc. (NASDAQ:GH)
Federated Hermes Inc. decreased its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 18.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 907,200 shares of the company'
Guardant Health (NASDAQ:GH) Trading Up 3.4%
Guardant Health (NASDAQ:GH) Trading Up 3.4%
Guardant Health (NASDAQ:GH) Sets New 12-Month Low Following Analyst Downgrade
Guardant Health (NASDAQ:GH) Hits New 52-Week Low on Analyst Downgrade
Guardant Health (NASDAQ:GH) PT Lowered to $28.00 at The Goldman Sachs Group
The Goldman Sachs Group cut their price objective on shares of Guardant Health from $32.00 to $28.00 and set a "buy" rating for the company in a report on Monday.
6,178,812 Shares in Guardant Health, Inc. (NASDAQ:GH) Purchased by Baillie Gifford & Co.
Baillie Gifford & Co. purchased a new stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 6,178,812 shares of the company's stock, valued at approximately $167
Guardant Health (NASDAQ:GH) Stock Price Up 4.9%
Guardant Health (NASDAQ:GH) Trading 4.9% Higher
Guggenheim Reaffirms Neutral Rating for Guardant Health (NASDAQ:GH)
Guggenheim reiterated a "neutral" rating on shares of Guardant Health in a research report on Friday.
Guardant Health
Guardant Health (NASDAQ:GH) Shares Gap Up to $20.25
Guardant Health (NASDAQ:GH) Shares Gap Up to $20.25
Guardant Health (NASDAQ:GH) Trading Down 5.8%
Guardant Health (NASDAQ:GH) Stock Price Down 5.8%
Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.

This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

GH Media Mentions By Week

GH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GH
News Sentiment

0.62

0.42

Average
Medical
News Sentiment

GH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GH Articles
This Week

9

4

GH Articles
Average Week

Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:GH) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners